Home
ArticlesArticles“We are delighted to build this alliance with the Exeltis team, addressing the needs of an underserved patient population. With an addressable market exceeding €200 million globally and a formulation tailored for a specific segment of rare disease patients, this partnership reflects our shared commitment to advancing therapeutic innovation and improving patient outcomes.
Under the terms of the agreement, Exeltis will acquire exclusive rights to market and distribute Theranexus’ proprietary product across key regions, including the European Union, UK, Latin America, and selected Middle Eastern countries. This collaboration will target both Gaucher and Niemann-Pick type C diseases. The agreement includes a 2 M€ upfront payment to Theranexus and aggregated development and commercial milestone payments. Theranexus will also receive tiered double-digit royalties on Exeltis’ net sales, reflecting the anticipated growth and impact of this novel therapeutic approach. Whole or part of the upfront and development milestones already paid at that time may be refunded to Exeltis should Theranexus not provide the documentation to support filing of a market approval application by October 31st, 2025.
MistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorthMistoftheNorth
11th edition of Thailand’s leading medical and healthcare exhibition, will return from 10 – 12 September 2025 at BITEC, Bangkok, setting new records in scale and scope. Organised by Messe Düsseldorf Asia, the exhibition will feature 1,000 exhibitors from 40 countries and regions, 20 national and group pavilions, and is expected to welcome thousands of trade visitors, hosted buyers, and healthcare professionals from across ASEAN and beyond.
The backbone of zero-click care – passive patient engagement by way of ambient sensing and also IoT in hospitals
A crucial enabler of zero-click care happens to be the integration of artificial intelligence as well as predictive analytics into the hospital IT ecosystem. By way of evaluating
Altium is a cloud-based PCB design tool that allows you to work from any device with an internet connection, take your work with you, and collaborate with your team in real time. With real-time data, advanced analytics and artificial intelligence as their underpinnings, these virtual counterparts of physical objects, systems or processes aim to revolutionize patient care and operational efficiency throughout the healthcare system.
Researchers have unveiled new therapies targeting chronic conditions such as diabetes and heart disease, promising improved outcomes for millions worldwide
